BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22711852)

  • 21. Ogilvie's syndrome (colonic pseudo-obstruction) occurring in an 18-year-old Nigerian female.
    Irabor DO; Ladipo JK; Ogunsanya WF; Akra G; Oladoyin O; Aimakhu C
    West Afr J Med; 2001; 20(1):75-7. PubMed ID: 11505895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ogilvie's syndrome. A clinical case report].
    Giammanco M
    Minerva Chir; 1997 May; 52(5):655-7. PubMed ID: 9297157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute colonic pseudoobstruction in a child with sickle cell disease treated with neostigmine.
    Khosla A; Ponsky TA
    J Pediatr Surg; 2008 Dec; 43(12):2281-4. PubMed ID: 19040954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute colonic pseudo-obstruction in postchemotherapy complication of brain tumor treated with neostigmine.
    Kim TS; Lee JW; Kim MJ; Park YS; Lee DH; Chung NG; Cho B; Lee S; Kim HK
    J Pediatr Hematol Oncol; 2007 Jun; 29(6):420-2. PubMed ID: 17551407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of polyethylene glycol electrolyte balanced solution on patients with acute colonic pseudo obstruction after resolution of colonic dilation: a prospective, randomised, placebo controlled trial.
    Sgouros SN; Vlachogiannakos J; Vassiliadis K; Bergele C; Stefanidis G; Nastos H; Avgerinos A; Mantides A
    Gut; 2006 May; 55(5):638-42. PubMed ID: 16306137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis.
    Kiewe P; Fischer L; Martus P; Thiel E; Korfel A
    Cancer; 2008 Apr; 112(8):1812-20. PubMed ID: 18318432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo-obstruction: a prospective study.
    Mehta R; John A; Nair P; Raj VV; Mustafa CP; Suvarna D; Balakrishnan V
    J Gastroenterol Hepatol; 2006 Feb; 21(2):459-61. PubMed ID: 16509875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of relapsed central nervous system lymphoma with high-dose methotrexate.
    Plotkin SR; Betensky RA; Hochberg FH; Grossman SA; Lesser GJ; Nabors LB; Chon B; Batchelor TT
    Clin Cancer Res; 2004 Sep; 10(17):5643-6. PubMed ID: 15355887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [II. Primary treatment of CNS lymphoma with high-dose MTX].
    Iwadate Y
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):892-7. PubMed ID: 22880222
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ogilvie's syndrome and non-mechanical obstructions].
    Bloch P; Contou JF
    Rev Prat; 1993 Mar; 43(6):711-5. PubMed ID: 8341948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled transperitoneal percutaneous cecostomy as a therapeutic alternative to the endoscopic decompression for Ogilvie's syndrome.
    Chevallier P; Marcy PY; Francois E; Peten EP; Motamedi JP; Padovani B; Bruneton JN
    Am J Gastroenterol; 2002 Feb; 97(2):471-4. PubMed ID: 11866290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Managing methotrexate toxicity: a case report].
    Fernández Megía MJ; Alós Almiñana M; Terol Castera MJ
    Farm Hosp; 2004; 28(5):371-4. PubMed ID: 15504095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ogilvie's syndrome--acute colonic pseudo-obstruction. Case report and review of the literature.
    Georgescu S; Dubei L; Zaharia M; Cîrdei C; Crumpei F; Cijevschi-Prelipcean C; Stoian M
    Rom J Gastroenterol; 2003 Mar; 12(1):51-5. PubMed ID: 12673381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ogilvie's syndrome (acute colonic pseudo-obstruction): review of the literature and report of 6 additional cases.
    Grassi R; Cappabianca S; Porto A; Sacco M; Montemarano E; Quarantelli M; Di Mizio R; De Rosa R
    Radiol Med; 2005 Apr; 109(4):370-5. PubMed ID: 15883521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Favorable response to cisapride in acute colonic pseudo-obstruction (Ogilvie's syndrome)].
    Artal A; Freile E; Lanas A
    Rev Esp Enferm Dig; 1994 Aug; 86(2):615-8. PubMed ID: 7946609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controversies in primary CNS lymphoma.
    Abrey LE
    Expert Rev Neurother; 2005 Jul; 5(4):459-64. PubMed ID: 16026229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukocytoclastic Vasculitis and Desensitization to High-dose Methotrexate in Primary Central Nervous System Lymphoma.
    Hanna C; Villa D; Irani C; Ghosn M; El Rassy E
    Clin Lymphoma Myeloma Leuk; 2018 May; 18(5):e197-e200. PubMed ID: 29605422
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acute colonic pseudoobstruction: Ogilvie's syndrome].
    Trenin SO; Shishkov AV; Maslennikov VA; Keropian OK
    Khirurgiia (Mosk); 2007; (4):32-8. PubMed ID: 17690630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Successful conservative treatment of coecal perforation in a patient with Ogilvie's syndrome].
    Lang CL; Haveman MC; Achiam M
    Ugeskr Laeger; 2013 Apr; 175(16):1120-1. PubMed ID: 23651754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS.
    Jacomet C; Girard PM; Lebrette MG; Farese VL; Monfort L; Rozenbaum W
    AIDS; 1997 Nov; 11(14):1725-30. PubMed ID: 9386807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.